COVID-19 eroded gains made in Tuberculosis control
|
''The
African region is faced with a high number of drug-resistant TB cases. In
2019, about 83% of TB deaths among HIV-negative people occurred in ... |
FDA slaps clinical hold on multiple Gilead HIV trials
Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid safety concerns. View article...